Nature Cancer Publishes THREADS Pathology Foundation Model
Mass General Brigham’s THREADS pathology model is published in Nature Cancer after a Jan 2025 preprint. It is a research result, not a clinical product.
Latest
Lupus Patients’ Immune Cells Target Proteins Made by Splicing Errors
Lupus neoantigens made by faulty mRNA splicing in neutrophils drew T and B cell responses, a Nature study finds. Trials must test if they drive disease.
26% of Fetal Neurons Carry Big DNA Errors, Falling to 6% After Birth
A Nature study of 2,357 brain cells finds about a quarter of fetal neurons carry widespread DNA copy changes, falling to about 6% after birth.
AI Screened 6,680 Molecules and Helped Find a New Antibiotic, Abaucin
An AI model ranked 6,680 compounds in under two hours and helped find abaucin, which treated superbug infections in mice. It isn't a medicine yet.
AI-Edited Antibody Bound IL-6 13 Times More Tightly in Lab Tests
AbOptimizer edited three therapeutic antibodies with an AI model and reinforcement learning. One bound IL-6 13 times more tightly, in lab tests only.
3D-Printed Holograms Steer Ultrasound to Stroke Damage in Mice
ShanghaiTech researchers used 3D-printed acoustic holograms and one ultrasound transducer to deliver stem-cell therapy around stroke damage in male mice.
KRAS Pancreatic Cancer Vaccine Misses Main Goal but Primes T Cells
An off-the-shelf KRAS vaccine missed its main goal in a 144-patient pancreatic cancer trial, but 89 of 90 evaluable patients mounted a T-cell response.
Early NIH-Led Trial Finds T-Cell Drug Invika Stalls Resistant Tumours
In an early trial led by NIH researchers, T-cell drug invika stopped cancer growing in 16 of 27 patients at the optimal dose and shrank tumours in four.
Personalised mRNA Therapy Cuts Melanoma Recurrence or Death Risk 42%
In a 1,137-patient phase 3 trial, intismeran plus Keytruda cut the risk of melanoma recurrence or death by 42%. Survival data are not yet mature.
The Drug Was Designed by an AI: How Insilico and Lilly Just Changed Medicine Forever
Something remarkable is happening in a lab you've never heard of, funded by a deal that barely made the news cycle. Last week, Eli Lilly — one...
AI Just Designed a Drug That Kills Superbugs Without Harming Good Bacteria
AI Just Designed a Drug That Kills Superbugs Without Harming Good Bacteria
MIT researchers used artificial intelligence to create NG1 — a precision antibiotic that...
Related stories
Latest from topics connected to Medicine. See all with connected topics
Latest on TSN
Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.



